Jukka Jokinen

Summary

Publications

  1. doi request reprint Acute otitis media replacement and recurrence in the Finnish otitis media vaccine trial
    Jukka Jokinen
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    Clin Infect Dis 55:1673-6. 2012
  2. ncbi request reprint Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial
    Arto A Palmu
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Tampere, Finland Electronic address
    Lancet Infect Dis 14:205-12. 2014
  3. ncbi request reprint Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media
    Arto A Palmu
    National Institute for Health and Welfare, Helsinki, Finland Tampere School of Public Health, Tampere, Finland
    Vaccine 27:1490-1. 2009
  4. ncbi request reprint Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements
    Ilona Sarasoja
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Tampere, Finland
    Pediatr Infect Dis J 32:517-20. 2013
  5. doi request reprint Presence of capsular locus genes in immunochemically identified encapsulated and unencapsulated Streptococcus pneumoniae sputum isolates obtained from elderly patients with acute lower respiratory tract infection
    Paula Kurola
    National Institute for Health and Welfare, Oulu, Finland
    J Med Microbiol 59:1140-5. 2010
  6. ncbi request reprint Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate v
    Terhi Kilpi
    National Public Health Institute KTL, Helsinki, Finland
    Clin Infect Dis 37:1155-64. 2003
  7. doi request reprint Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine
    Arto Palmu
    National Public Health Institute, Helsinki, Finland Tampere School of Public Health, Tampere, Finland
    Vaccine 26:2466-70. 2008
  8. doi request reprint Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study
    Arto A Palmu
    From the National Institute for Health and Welfare, Helsinki, Finland
    Scand J Infect Dis 46:250-9. 2014
  9. doi request reprint Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
    Arto A Palmu
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Tampere, Finland
    Lancet 381:214-22. 2013
  10. pmc Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine
    Birgit Simell
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare THL, Helsinki, Finland
    Clin Vaccine Immunol 19:96-9. 2012

Detail Information

Publications13

  1. doi request reprint Acute otitis media replacement and recurrence in the Finnish otitis media vaccine trial
    Jukka Jokinen
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    Clin Infect Dis 55:1673-6. 2012
    ..We found evidence of replacement disease occurring early during the trial follow-up and little vaccine impact on recurrent overall AOM episodes...
  2. ncbi request reprint Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial
    Arto A Palmu
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Tampere, Finland Electronic address
    Lancet Infect Dis 14:205-12. 2014
    ..We assessed the effect of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10; GlaxoSmithKline) on antimicrobial purchases...
  3. ncbi request reprint Efficacy of pneumococcal conjugate vaccine against PCR-positive acute otitis media
    Arto A Palmu
    National Institute for Health and Welfare, Helsinki, Finland Tampere School of Public Health, Tampere, Finland
    Vaccine 27:1490-1. 2009
    ..The data do not support effect of PncCRM on AOM in which only Ply-PCR suggests pneumococcal etiology...
  4. ncbi request reprint Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements
    Ilona Sarasoja
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Tampere, Finland
    Pediatr Infect Dis J 32:517-20. 2013
    ..This study aimed to assess the effectiveness of pneumococcal conjugate vaccines PncCRM and PncOMPC from 2 up to 13 years of age...
  5. doi request reprint Presence of capsular locus genes in immunochemically identified encapsulated and unencapsulated Streptococcus pneumoniae sputum isolates obtained from elderly patients with acute lower respiratory tract infection
    Paula Kurola
    National Institute for Health and Welfare, Oulu, Finland
    J Med Microbiol 59:1140-5. 2010
    ..002). The cpsB PCR developed here was found to be a rapid and reliable method to detect the pneumococcal capsule locus and may have potential in sputum diagnostics when investigating the pneumococcal aetiology of CAP...
  6. ncbi request reprint Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate v
    Terhi Kilpi
    National Public Health Institute KTL, Helsinki, Finland
    Clin Infect Dis 37:1155-64. 2003
    ..The 2 boosters seemed to provide equal protection against AOM, but PncPS induced markedly higher antibody concentrations. The efficacy of PncOMPC was comparable to that of the recently licensed pneumococcal conjugate vaccine...
  7. doi request reprint Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine
    Arto Palmu
    National Public Health Institute, Helsinki, Finland Tampere School of Public Health, Tampere, Finland
    Vaccine 26:2466-70. 2008
    ..We were not able to show that the differences between the study results would be due to the case definitions used...
  8. doi request reprint Incidence and etiology of community-acquired pneumonia in the elderly in a prospective population-based study
    Arto A Palmu
    From the National Institute for Health and Welfare, Helsinki, Finland
    Scand J Infect Dis 46:250-9. 2014
    ..Specific objectives were to demonstrate setting feasibility, to construct a case definition for Pnc CAP, and to estimate its incidence...
  9. doi request reprint Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
    Arto A Palmu
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Tampere, Finland
    Lancet 381:214-22. 2013
    ....
  10. pmc Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine
    Birgit Simell
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare THL, Helsinki, Finland
    Clin Vaccine Immunol 19:96-9. 2012
    ..Higher anti-serotype 14 and anti-serotype 19F IgG and anti-serotype 14 IgM correlated with a lowered probability of pneumococcal acquisition. Postvaccination OPA did not correlate with pneumococcal carriage...
  11. ncbi request reprint The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children
    Arto A I Palmu
    National Public Health Institute, Helsinki, Finland
    Pediatr Infect Dis J 23:732-8. 2004
    ..Our aim was to assess long term efficacy of the vaccine on tympanostomy tube placements...
  12. pmc AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland
    Hanna Nohynek
    Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland
    PLoS ONE 7:e33536. 2012
    ..A sudden increase in childhood narcolepsy was observed in Finland soon after pandemic influenza epidemic and vaccination with ASO3-adjuvanted Pandemrix. No increase was observed in other age groups...
  13. ncbi request reprint Viral etiology of frequently recurring respiratory tract infections in children
    Johanna Nokso-Koivisto
    Department of Microbiology, National Public Health Institute, Helsinki, Finland
    Clin Infect Dis 35:540-6. 2002
    ..In conclusion, a specific viral etiology does not explain the excess of URI episodes in children with FRRI...